Annual D&A
$10.17 M
+$975.00 K+10.60%
31 December 2023
Summary:
Vaxcyte annual depreciation & amortization is currently $10.17 million, with the most recent change of +$975.00 thousand (+10.60%) on 31 December 2023. During the last 3 years, it has risen by +$8.77 million (+623.91%). PCVX annual D&A is now at all-time high.PCVX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$4.49 M
+$1.01 M+29.13%
30 September 2024
Summary:
Vaxcyte quarterly depreciation & amortization is currently $4.49 million, with the most recent change of +$1.01 million (+29.13%) on 30 September 2024. Over the past year, it has increased by +$2.01 million (+81.09%). PCVX quarterly D&A is now at all-time high.PCVX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$14.01 M
+$2.01 M+16.76%
30 September 2024
Summary:
Vaxcyte TTM depreciation & amortization is currently $14.01 million, with the most recent change of +$2.01 million (+16.76%) on 30 September 2024. Over the past year, it has increased by +$4.49 million (+47.10%). PCVX TTM D&A is now at all-time high.PCVX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.6% | +81.1% | +47.1% |
| 3 y3 years | +623.9% | +424.6% | +442.3% |
| 5 y5 years | +880.8% | +1377.3% | +1456.4% |
PCVX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +623.9% | at high | +424.6% | at high | +442.3% |
| 5 y | 5 years | at high | +880.8% | at high | +1377.3% | at high | +1456.4% |
| alltime | all time | at high | +880.8% | at high | +1427.5% | at high | +4664.6% |
Vaxcyte Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.49 M(+29.1%) | $14.01 M(+16.8%) |
| June 2024 | - | $3.48 M(+12.5%) | $12.00 M(+9.9%) |
| Mar 2024 | - | $3.09 M(+4.9%) | $10.92 M(+7.4%) |
| Dec 2023 | $10.17 M(+10.6%) | $2.95 M(+18.9%) | $10.17 M(+6.8%) |
| Sept 2023 | - | $2.48 M(+3.3%) | $9.52 M(+1.3%) |
| June 2023 | - | $2.40 M(+2.5%) | $9.40 M(+2.5%) |
| Mar 2023 | - | $2.34 M(+1.8%) | $9.17 M(-0.3%) |
| Dec 2022 | $9.20 M(+166.0%) | $2.30 M(-2.3%) | $9.20 M(+13.5%) |
| Sept 2022 | - | $2.35 M(+8.3%) | $8.10 M(+22.7%) |
| June 2022 | - | $2.17 M(-8.3%) | $6.60 M(+24.6%) |
| Mar 2022 | - | $2.37 M(+96.4%) | $5.30 M(+53.3%) |
| Dec 2021 | $3.46 M | $1.21 M(+40.9%) | $3.46 M(+33.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $856.00 K(-1.4%) | $2.58 M(+25.3%) |
| June 2021 | - | $868.00 K(+64.7%) | $2.06 M(+33.1%) |
| Mar 2021 | - | $527.00 K(+58.7%) | $1.55 M(+10.2%) |
| Dec 2020 | $1.41 M(+14.0%) | $332.00 K(-0.6%) | $1.41 M(0.0%) |
| Sept 2020 | - | $334.00 K(-5.9%) | $1.41 M(+2.2%) |
| June 2020 | - | $355.00 K(-7.6%) | $1.38 M(+4.0%) |
| Mar 2020 | - | $384.00 K(+15.7%) | $1.32 M(+7.3%) |
| Dec 2019 | $1.23 M(+18.8%) | $332.00 K(+9.2%) | $1.23 M(+36.9%) |
| Sept 2019 | - | $304.00 K(+0.7%) | $900.00 K(+51.0%) |
| June 2019 | - | $302.00 K(+2.7%) | $596.00 K(+102.7%) |
| Mar 2019 | - | $294.00 K | $294.00 K |
| Dec 2018 | $1.04 M | - | - |
FAQ
- What is Vaxcyte annual depreciation & amortization?
- What is the all time high annual D&A for Vaxcyte?
- What is Vaxcyte annual D&A year-on-year change?
- What is Vaxcyte quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Vaxcyte?
- What is Vaxcyte quarterly D&A year-on-year change?
- What is Vaxcyte TTM depreciation & amortization?
- What is the all time high TTM D&A for Vaxcyte?
- What is Vaxcyte TTM D&A year-on-year change?
What is Vaxcyte annual depreciation & amortization?
The current annual D&A of PCVX is $10.17 M
What is the all time high annual D&A for Vaxcyte?
Vaxcyte all-time high annual depreciation & amortization is $10.17 M
What is Vaxcyte annual D&A year-on-year change?
Over the past year, PCVX annual depreciation & amortization has changed by +$975.00 K (+10.60%)
What is Vaxcyte quarterly depreciation & amortization?
The current quarterly D&A of PCVX is $4.49 M
What is the all time high quarterly D&A for Vaxcyte?
Vaxcyte all-time high quarterly depreciation & amortization is $4.49 M
What is Vaxcyte quarterly D&A year-on-year change?
Over the past year, PCVX quarterly depreciation & amortization has changed by +$2.01 M (+81.09%)
What is Vaxcyte TTM depreciation & amortization?
The current TTM D&A of PCVX is $14.01 M
What is the all time high TTM D&A for Vaxcyte?
Vaxcyte all-time high TTM depreciation & amortization is $14.01 M
What is Vaxcyte TTM D&A year-on-year change?
Over the past year, PCVX TTM depreciation & amortization has changed by +$4.49 M (+47.10%)